I. L. Staveren

发表

Decreased expression of EZH 2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer

Look, S. Sleijfer, J. Foekens, 2019 .

Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer

S. Sleijfer, J. Foekens, A. Sieuwerts, 2010, Breast Cancer Research and Treatment.

Complete Sequencing of TP 53 Predicts Poor Response to Systemic Therapy of Advanced Breast Cancer 1

R. Vossen, J. Foekens, J. Klijn, 2000 .

Downregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancer

S. Sleijfer, J. Foekens, J. Klijn, 2009, Breast Cancer Research and Treatment.

Prognostic factors in human primary breast cancer: Comparison of c-myc and HER2/neu amplification

J. Foekens, J. Klijn, E. Berns, 1992, The Journal of Steroid Biochemistry and Molecular Biology.

TSC22D1 and PSAP predict clinical outcome of tamoxifen treatment in patients with recurrent breast cancer

J. Foekens, A. Sieuwerts, M. Look, 2008, Breast Cancer Research and Treatment.

Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer.

R. Vossen, J. Foekens, J. Klijn, 2000, Cancer research.

c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer.

J. Foekens, J. Klijn, E. Berns, 1992, Cancer research.

Sporadic amplification of the insulin-like growth factor 1 receptor gene in human breast tumors.

J. Foekens, J. Klijn, E. Berns, 1992, Cancer research.

TSC22D1 and PSAP predict clinical outcome of tamoxifen treatment in patients with recurrent breast cancer

J. Foekens, A. Sieuwerts, M. Look, 2008, Breast Cancer Research and Treatment.